Laparoscopic sleeve gastrectomy as treatment for morbid obesity: Technique and short-term outcome

被引:192
作者
Roa, Paul E.
Kaidar-Person, Orit
Pinto, David
Cho, Minyoung
Szomstein, Samuel
Rosenthal, Raul J.
机构
[1] Cleveland Clin Florida, Bariatr Inst, Dept Surg, Weston, FL 33331 USA
[2] Cleveland Clin Florida, Sect Minimal Invas Surg, Weston, FL 33331 USA
[3] Korea Univ, Dept Surg, Coll Med, Seoul 136701, South Korea
关键词
laparoscopy; sleeve gastrectomy; morbid obesity; bariatric surgery; restrictive procedure;
D O I
10.1381/096089206778663869
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Laparoscopic Roux-en-Y gastric bypass (LRYGBP) and laparoscopic adjustable gastric banding (LAGB) are the most commonly performed surgical procedures for weight reduction in the United States. Currently, laparoscopic sleeve gastrectomy (LSG) is being explored. The aim of this study was to assess the safety and short-term efficacy of LSG as a treatment option for weight reduction. Methods: Data of all patients who underwent LSG for treatment of morbid obesity between November 2004 and March 2006 and completed the 3- and 6-month follow-up visits at the time of the study, were retrospectively reviewed. Data collected included demographics, operative time, length of stay, postoperative complications, and degree of weight reduction. Results: Of the 62 patients who underwent LSG performed by two surgeons, the data of 30 patients,(7 males and 23 females) were further analyzed. Mean preoperative BMI was 41.4 (33-59) kg/m(2). Mean operative time was 80 min (range 65-130). Mean hospital stay was 3.2 days (range 2 to 25). Mean weight loss at 3 and 6 months following the procedure was 22.7 kg and 30.5 kg respectively, and mean % excess weight loss (EWL) was 40.7 and 52.8, respectively. Three patients were considered to have mild complications, and one patient had a major complication that necessitated surgical intervention. There was no mortality. Conclusions: In the short-term, LSG is a safe and effective treatment option.
引用
收藏
页码:1323 / 1326
页数:4
相关论文
共 15 条
[1]   Longitudinal gastrectomy as a treatment for the high-risk super-obese patient [J].
Almogy, G ;
Crookes, PF ;
Anthone, GJ .
OBESITY SURGERY, 2004, 14 (04) :492-497
[2]   Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans [J].
Ariyasu, H ;
Takaya, K ;
Tagami, T ;
Ogawa, Y ;
Hosoda, K ;
Akamizu, T ;
Suda, M ;
Koh, T ;
Natsui, K ;
Toyooka, S ;
Shirakami, G ;
Usui, T ;
Shimatsu, A ;
Doi, K ;
Hosoda, H ;
Kojima, M ;
Kangawa, K ;
Nakao, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (10) :4753-4758
[3]   Laparoscopic sleeve gastrectomy:: A multi-purpose bariatric operation [J].
Baltasar, A ;
Serra, C ;
Pérez, N ;
Bou, R ;
Bengochea, M .
OBESITY SURGERY, 2005, 15 (08) :1124-1128
[4]   Recommendations for reporting weight loss [J].
Deitel, M ;
Greenstein, RJ .
OBESITY SURGERY, 2003, 13 (02) :159-160
[5]  
Han SM, 2005, OBES SURG, V15, P1469
[6]   The biliopancreatic diversion with the duodenal switch: Results beyond 10 years [J].
Hess, DS ;
Hess, DW ;
Oakley, RS .
OBESITY SURGERY, 2005, 15 (03) :408-416
[7]   Biliopancreatic diversion with a duodenal switch [J].
Hess, DS ;
Hess, DW .
OBESITY SURGERY, 1998, 8 (03) :267-282
[8]   Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity? [J].
Langer, FB ;
Bohdjalian, A ;
Felberbauer, FX ;
Fleischmann, E ;
Hoda, MAR ;
Ludvik, B ;
Zacherl, J ;
Jakesz, R ;
Prager, G .
OBESITY SURGERY, 2006, 16 (02) :166-171
[9]   Sleeve gastrectomy and gastric banding: Effects on plasma ghrelin levels [J].
Langer, FB ;
Hoda, MAR ;
Bohdjalian, A ;
Felberbauer, FX ;
Zacherl, J ;
Wenzl, E ;
Schindler, K ;
Luger, A ;
Ludvik, B ;
Prager, G .
OBESITY SURGERY, 2005, 15 (07) :1024-1029
[10]   BILIOPANCREATIC DIVERSION WITH A NEW TYPE OF GASTRECTOMY [J].
MARCEAU, P ;
BIRON, S ;
BOURQUE, RA ;
POTVIN, M ;
HOULD, FS ;
SIMARD, S .
OBESITY SURGERY, 1993, 3 (01) :29-35